Absconding for years, mastermind behind inter-state illegal drug syndicate lands in police net

Jaipur:  In a significant breakthrough, the Anti-Narcotics Task Force (ANTF) of Rajasthan’s Special Operations Group (SOG) has arrested the mastermind behind a multi-crore illegal drug syndicate operating through fake firms in Nagaland, Assam, Gurugram, and Nepal. The accused, Sushil Karnani, had been on the run since 2021 and was arrested in Nepal on May 25, an official said on Monday.

A resident of Nokha, Bikaner, he had a reward of Rs 50,000 on his head. He was presented in the NDPS court in Ajmer on Monday and has been sent to six-day police remand.

Authorities will now question him to trace other absconding members of the network.

According to SP Satvir Singh of the ANTF, a case was first registered in 2021 at Ramganj Police Station, Ajmer, after a major drug seizure.

Investigations revealed that Karnani had established fake pharmaceutical firms in Nagaland and other regions to illegally purchase narcotics. These drugs were then trafficked to Rajasthan and Uttar Pradesh.

The racket used false documents and stolen identities to register companies and procure restricted pharmaceutical drugs, primarily ‘Tramadol’, known for its high abuse potential.

The case gained prominence after a series of massive drug hauls in 2021.

On May 3, 2021, Vishwakarma Police, Jaipur, seized a tempo carrying Rs 5 crore worth of narcotic medicines and arrested Mohammad Tahir. On May 24, 2021, a total of 114 cartons of illegal antibiotics were seized from a warehouse in Transport Nagar, Ajmer, valued at Rs 5.5 crore.

On June 1, 2021, joint teams from Ramganj and Alwar Gate police stations recovered 110 cartons of banned medicines worth Rs 55.3 crore, containing over 3.5 million tablets, injections, and syrups. In total, drugs worth over Rs 16 crore were recovered in this case across Jaipur and Ajmer.

Special Public Prosecutor Shashi Prakash Indouria revealed that Karnani had created fake companies using the documents of unsuspecting individuals, some of whom were unaware that businesses were being run under their names.

The syndicate used these bogus firms to order prescription drugs in bulk, violating the Narcotic Drugs and Psychotropic Substances (NDPS) Act.

Many of these substances are tightly regulated due to their potential for abuse. So far, seven accused have been arrested in the case.

With Karnani now in custody, the police hope to unravel the entire network, track down remaining absconders, and dismantle the supply chain, an official said.

Related Posts

Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

New Delhi: Serious legal gaps in the Drugs and Cosmetics Act, 1940, combined with acute shortages of manpower and infrastructure, continue to impede the Central Drugs Standard Control Organisation (CDSCO)…

Patna HC Rules Phenothiazine & Promethazine Not Narcotic Or Psychotropic Substances Under NDPS Act

Patna: In a significant ruling that could have far-reaching implications for NDPS drug-related prosecutions involving common pharmaceutical compounds, the Patna High Court has held that Phenothiazine and Promethazine do not…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

Patna HC Rules Phenothiazine & Promethazine Not Narcotic Or Psychotropic Substances Under NDPS Act

Patna HC Rules Phenothiazine & Promethazine Not Narcotic Or Psychotropic Substances Under NDPS Act

COMT Inhibitors May Fuel Gut Bacteria That Degrade Levodopa In Parkinson’s Patients

COMT Inhibitors May Fuel Gut Bacteria That Degrade Levodopa In Parkinson’s Patients

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

IPC releases draft NFI-2026 to promote rational use of medicines

IPC releases draft NFI-2026 to promote rational use of medicines